Terbutaline
- Generic Name
- Terbutaline
- Brand Names
- Bricanyl
- Drug Type
- Small Molecule
- Chemical Formula
- C12H19NO3
- CAS Number
- 23031-25-6
- Unique Ingredient Identifier
- N8ONU3L3PG
- Background
Terbutaline was first synthesized in 1966 and described in the literature in the late 1960s and early 1970s. It is a selective beta-2 adrenergic agonist used as a bronchodilator in asthmatic patients.
Terbutaline was granted FDA approval on 25 March 1974.
- Indication
Terbutaline is indicated for prevention and reversal of bronchospasm in patients at least 12 years old, with asthma and reversible bronchospasm associated with bronchitis and emphysema.
- Associated Conditions
- Asthma, Bronchospasm, Chronic Cough (CC), Chronic Obstructive Pulmonary Disease (COPD), Cough, Premature Labour, Productive cough
- Associated Therapies
- Airway secretion clearance therapy
Comparing the Efficacy of Bricanyl M2 and Bricanyl M3 at 0.5 and 1.5 mg Dose Levels, to Allow for a Switch From Bricanyl Turbuhaler M2 to Bricanyl Turbuhaler M3
- Conditions
- Interventions
- First Posted Date
- 2014-12-23
- Last Posted Date
- 2017-01-13
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 95
- Registration Number
- NCT02322788
- Locations
- 🇸🇪
Research Site, Lund, Sweden
β2-agonist Versus Ipratropium Bromide Associated With β2-agonists in Chronic Obstructive Pulmonary Disease Exacerbation
- Conditions
- Interventions
- First Posted Date
- 2013-09-17
- Last Posted Date
- 2018-01-26
- Lead Sponsor
- University of Monastir
- Target Recruit Count
- 250
- Registration Number
- NCT01944033
- Locations
- 🇹🇳
University Hospital of Monastir, Monastir,, Monastir, Tunisia
🇹🇳Fattouma Bourguiba University Hospital, Monastir, Tunisia
Intravenous Terbutaline to Facilitate Labor Epidural Catheter Placement
- First Posted Date
- 2012-07-27
- Last Posted Date
- 2015-01-19
- Lead Sponsor
- Kai Schoenhage
- Target Recruit Count
- 250
- Registration Number
- NCT01651962
- Locations
- 🇺🇸
University of Arizona Medical Center, Tucson, Arizona, United States
🇺🇸Tucson Medical Center, Tucson, Arizona, United States
Comparing Symbicort® As-Needed or Bricanyl As-Needed or Pulmicort® Once Daily + Bricanyl As-Needed in Asthma Patients
- Conditions
- Interventions
- First Posted Date
- 2009-10-06
- Last Posted Date
- 2012-08-14
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 66
- Registration Number
- NCT00989833
- Locations
- 🇸🇪
Research Site, Uppsala, Sweden
Use of Terbutaline or a Reduction in Basal Insulin in the Prevention of Nocturnal Hypoglycemia
- Conditions
- Interventions
- First Posted Date
- 2009-09-10
- Last Posted Date
- 2013-10-11
- Lead Sponsor
- University of Colorado, Denver
- Target Recruit Count
- 16
- Registration Number
- NCT00974051
- Locations
- 🇺🇸
Barbara Davis Center, Aurora, Colorado, United States
Prn Budesonide/Formoterol Versus Regular Budesonide/Formoterol Plus Prn Terbutaline in Mild-Moderate Asthma
- Conditions
- Interventions
- First Posted Date
- 2009-02-23
- Last Posted Date
- 2014-05-30
- Lead Sponsor
- Università degli Studi di Ferrara
- Target Recruit Count
- 860
- Registration Number
- NCT00849095
- Locations
- 🇮🇹
Ospedale regionale Umberto I, Unità Operativa di Allergologia, Ancona, AN, Italy
🇮🇹Fondazione S. Maugeri - IRCCS -dipartimento di Pneumologia riabilitativa, Cassano delle Murge, BA, Italy
🇮🇹Giuseppina Bertorelli, Parma, Italy
A Pilot Study to Evaluate the Safety of Terbutaline in Children With Type 1 Diabetes
- First Posted Date
- 2008-02-05
- Last Posted Date
- 2016-09-05
- Lead Sponsor
- Jaeb Center for Health Research
- Target Recruit Count
- 9
- Registration Number
- NCT00607503
- Locations
- 🇺🇸
Division of Pediatric Endocrinology and Diabetes, Stanford University, Stanford, California, United States
🇺🇸Jaeb Center for Health Research, Tampa, Florida, United States
🇺🇸Department of Pediatrics, University of Iowa Carver College of Medicine, Iowa City, Iowa, United States
SHARE - Symbicort and Health Economics in a Real Life Evaluation
- Conditions
- First Posted Date
- 2005-12-01
- Last Posted Date
- 2011-01-24
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 1970
- Registration Number
- NCT00259766
- Locations
- 🇸🇪
Reseearch Site, Perstorp, Sweden
🇸🇪Research Site, Örebro, Sweden
🇸🇪Research site, Ödeshög, Sweden
Nitroglycerin Versus Terbutaline for Intrapartum Fetal Resuscitation
- First Posted Date
- 2005-09-16
- Last Posted Date
- 2011-03-08
- Lead Sponsor
- Stanford University
- Target Recruit Count
- 110
- Registration Number
- NCT00185887
- Locations
- 🇺🇸
Stanford University School of Medicine, Stanford, California, United States
Trial of Terbutaline for the Treatment of Status Asthmaticus in Children
- Conditions
- First Posted Date
- 2005-07-29
- Last Posted Date
- 2013-02-15
- Lead Sponsor
- Connecticut Children's Medical Center
- Target Recruit Count
- 40
- Registration Number
- NCT00124995
- Locations
- 🇺🇸
CT Children's Medical Center, Hartford, Connecticut, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.